Physician profile
James Block
NPI 1093277444
$825.83
in general payments reported to CMS, 2019-2025
16 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $405 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $826.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $825.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $146.49 | 2025 | Biktarvy |
| Pfizer INC. | $104.92 | 2024-2025 | |
| Lilly USA, LLC | $86.36 | 2024-2025 | Jardiance, Zepbound, Emgality |
| Viiv Healthcare Company | $81.79 | 2025 | Cabenuva, Apretude, Dovato |
| Astrazeneca Pharmaceuticals Lp | $64.29 | 2024 | Airsupra |
| Janssen Pharmaceuticals, INC | $61.35 | 2025 | Spravato |
| Novo Nordisk INC | $50.77 | 2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $47.83 | 2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $40.68 | 2024 | Gemtesa |
| Abbvie INC. | $30.56 | 2025 | |
| Amgen INC. | $28.11 | 2024 | Prolia, Evenity |
| Collegium Pharmaceutical, INC. | $24.14 | 2025 | Jornay Pm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.07 | 2024 | Jardiance, Synjardy |
| Merck Sharp & Dohme LLC | $14.84 | 2024 | Vaxelis, M-M-R II, Gardasil |
| Paratek Pharmaceuticals, INC. | $14.60 | 2025 | Nuzyra |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.03 | 2025 | Veozah |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Block listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.